PRAX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,085,042.44

Praxis Precision Medicines Insider Trading History Chart

Praxis Precision Medicines Share Price & Price History

^$71.76

▼ -5.12 (-6.66%)

As of 11/15/2024 01:00 AM ET

Days: 30 | 90 | 365

The Tesla Trade Is Back In Business

From WealthPress | Ad

If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.

Discover how to trade Tesla, simply follow this link here.

Praxis Precision Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/14/2024	Alex Nemiroff	General Counsel	Sell	8,239	$80.20	$660,767.80	10,301
11/14/2024	Lauren Mastrocola	Insider	Sell	5,188	$81.78	$424,274.64	5,613
10/5/2023	Jill Desimone	Director	Buy	966	$26.25	$25,357.50	966
6/27/2023	Marcio Souza	CEO	Buy	666	$15.90	$10,589.40	3,000
3/24/2023	Dean J Mitchell	Director	Buy	3,333	$12.60	$41,995.80	5,000
3/23/2023	Marcio Souza	CEO	Buy	2,333	$12.90	$30,095.70	15,086
6/16/2022	Lauren Mastrocola	Insider	Buy	200	$28.95	$5,790.00	2,092
6/13/2022	Alex Nemiroff	General Counsel	Buy	500	$24.45	$12,225.00	2,623
6/9/2022	Timothy Edwin Kelly	CFO	Buy	666	$26.40	$17,582.40	2,699
6/8/2022	Dean J Mitchell	Director	Buy	1,666	$27.15	$45,231.90	1,666
6/8/2022	Marcio Souza	CEO	Buy	1,800	$27.75	$49,950.00	12,612

Breaking News: Tesla headed to $500…

From WealthPress | Ad

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address.

SEC Filings (Institutional Ownership Changes) for Praxis Precision Medicines (NASDAQ:PRAX)

67.84% of Praxis Precision Medicines stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Praxis Precision Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2024	Barclays PLC	37,130	$2.14M	0.0%	+126.8%	0.199%
11/15/2024	Wellington Management Group LLP	219,907	$12.65M	0.0%	+326.9%	1.180%
11/15/2024	State Street Corp	789,624	$45.44M	0.0%	-3.6%	4.237%
11/15/2024	Quarry LP	1,000	$58K	0.0%	-50.0%	0.005%
11/15/2024	RA Capital Management L.P.	761,955	$43.84M	0.5%	-38.3%	4.088%
11/15/2024	Jacobs Levy Equity Management Inc.	39,999	$2.30M	0.0%	-36.9%	0.215%
11/15/2024	Janus Henderson Group PLC	523,566	$30.08M	0.0%	+37.2%	2.809%
11/15/2024	HighVista Strategies LLC	10,951	$0.63M	0.2%	N/A	0.059%
11/15/2024	Baker BROS. Advisors LP	323,105	$18.59M	0.2%	+145.6%	1.734%
11/14/2024	PFM Health Sciences LP	183,092	$10.54M	0.6%	-59.6%	0.982%
11/14/2024	Fred Alger Management LLC	10,423	$0.60M	0.0%	+301.7%	0.056%
11/14/2024	Verition Fund Management LLC	559,151	$32.17M	0.2%	-25.3%	3.000%
11/14/2024	Walleye Capital LLC	55,613	$3.20M	0.0%	N/A	0.298%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	15,868	$0.91M	0.0%	-27.5%	0.085%
11/14/2024	Ally Bridge Group NY LLC	73,185	$4.21M	2.3%	-52.3%	0.393%
11/14/2024	Acuta Capital Partners LLC	57,500	$3.31M	2.7%	-65.0%	0.308%
11/14/2024	MetLife Investment Management LLC	10,131	$0.58M	0.0%	+129.1%	0.054%
11/13/2024	Glenmede Trust Co. NA	4,173	$0.24M	0.0%	N/A	0.022%
11/13/2024	BNP Paribas Financial Markets	9,525	$0.55M	0.0%	+369.4%	0.051%
11/13/2024	FMR LLC	273,895	$15.76M	0.0%	-5.9%	1.469%
11/13/2024	The Manufacturers Life Insurance Company	35,139	$2.02M	0.0%	-0.5%	0.189%
11/12/2024	Charles Schwab Investment Management Inc.	137,052	$7.89M	0.0%	+188.7%	0.735%
11/9/2024	Intech Investment Management LLC	3,771	$0.22M	0.0%	N/A	0.021%
11/6/2024	CIBC Asset Management Inc	248,939	$14.32M	0.0%	+29.2%	1.402%
11/2/2024	Mesirow Financial Investment Management Inc.	4,006	$0.23M	0.0%	N/A	0.023%
10/28/2024	US Bancorp DE	2,289	$0.13M	0.0%	+35.9%	0.013%
10/23/2024	Assenagon Asset Management S.A.	10,096	$0.58M	0.0%	-48.9%	0.057%
10/23/2024	Moody Aldrich Partners LLC	31,605	$1.82M	0.3%	+29.6%	0.178%
10/3/2024	SG Americas Securities LLC	5,158	$0.30M	0.0%	N/A	0.030%
8/16/2024	Perceptive Advisors LLC	750,230	$31.03M	0.7%	-8.7%	4.385%
8/16/2024	Quarry LP	2,000	$83K	0.0%	N/A	0.012%
8/16/2024	Driehaus Capital Management LLC	264,688	$10.95M	0.1%	-0.7%	1.547%
8/15/2024	The Manufacturers Life Insurance Company	35,308	$1.46M	0.0%	+77.7%	0.206%
8/15/2024	Millennium Management LLC	90,909	$3.76M	0.0%	-48.6%	0.531%
8/14/2024	Squarepoint Ops LLC	13,348	$0.55M	0.0%	+108.4%	0.078%
8/14/2024	Fred Alger Management LLC	2,595	$0.11M	0.0%	-94.5%	0.015%
8/14/2024	Point72 Asset Management L.P.	1,051,701	$43.50M	0.1%	+10.2%	5.922%
8/14/2024	Marshall Wace LLP	248,381	$10.27M	0.0%	+105.2%	1.452%
8/14/2024	Tri Locum Partners LP	75,319	$3.12M	0.8%	-29.3%	0.440%
8/14/2024	Ally Bridge Group NY LLC	153,379	$6.34M	3.8%	-3.8%	0.897%
8/14/2024	Profund Advisors LLC	7,686	$0.32M	0.0%	N/A	0.045%
8/12/2024	Amalgamated Bank	597	$25K	0.0%	N/A	0.003%
8/9/2024	Renaissance Technologies LLC	75,433	$3.12M	0.0%	+523.2%	0.441%
8/9/2024	Dimensional Fund Advisors LP	6,888	$0.28M	0.0%	-54.2%	0.040%
8/6/2024	Ballentine Partners LLC	10,911	$0.45M	0.0%	N/A	0.064%
8/5/2024	Ovata Capital Management Ltd	40,000	$1.65M	0.9%	+100.0%	0.234%
8/3/2024	TD Asset Management Inc	51,312	$2.12M	0.0%	+46.6%	0.300%
8/1/2024	Rhumbline Advisers	22,192	$0.92M	0.0%	+14,500.0%	0.130%
8/1/2024	CIBC Asset Management Inc	192,667	$7.97M	0.0%	+0.2%	1.126%
8/1/2024	Hussman Strategic Advisors Inc.	21,000	$0.87M	0.2%	N/A	0.123%
7/26/2024	Bank of New York Mellon Corp	49,510	$2.05M	0.0%	N/A	0.289%
7/18/2024	Assenagon Asset Management S.A.	19,761	$0.82M	0.0%	-72.3%	0.115%
7/16/2024	PCG Wealth Advisors LLC	17,441	$0.72M	0.3%	+35.0%	0.102%
5/24/2024	Farallon Capital Management LLC	50,000	$3.05M	0.0%	N/A	0.292%
5/17/2024	RA Capital Management L.P.	828,380	$50.55M	0.6%	N/A	4.841%
5/16/2024	Jacobs Levy Equity Management Inc.	51,548	$3.15M	0.0%	-22.5%	0.301%
5/16/2024	Janus Henderson Group PLC	310,059	$18.88M	0.0%	N/A	1.812%
5/16/2024	Kingdon Capital Management L.L.C.	350,000	$21.36M	2.3%	+1.0%	2.046%
5/15/2024	Price T Rowe Associates Inc. MD	535,999	$32.71M	0.0%	N/A	3.133%
5/14/2024	StemPoint Capital LP	26,893	$1.64M	0.4%	N/A	0.157%
5/14/2024	Boulder Hill Capital Management LP	4,200	$0.26M	0.1%	N/A	0.025%
5/10/2024	Acadian Asset Management LLC	82,254	$5.02M	0.0%	-16.1%	0.481%
5/10/2024	Vanguard Group Inc.	744,069	$45.40M	0.0%	+100.6%	4.349%
5/7/2024	SG Americas Securities LLC	2,465	$0.15M	0.0%	N/A	0.014%
5/2/2024	Chase Investment Counsel Corp	3,768	$0.23M	0.1%	N/A	0.022%
5/1/2024	BNP Paribas Financial Markets	6,750	$0.41M	0.0%	N/A	0.051%
4/24/2024	Assenagon Asset Management S.A.	71,253	$4.35M	0.0%	N/A	0.538%
4/22/2024	Windmill Hill Asset Management Ltd	5,268	$0.32M	0.1%	N/A	0.040%
4/19/2024	PCG Wealth Advisors LLC	12,917	$0.79M	0.4%	N/A	0.098%
3/18/2024	Kingdon Capital Management L.L.C.	346,665	$7.72M	1.0%	-93.3%	2.618%
2/15/2024	PFM Health Sciences LP	656,548	$14.63M	0.9%	-92.6%	7.468%
2/15/2024	Blackstone Inc.	70,273	$1.57M	0.0%	-93.3%	0.799%
2/14/2024	72 Investment Holdings LLC	65,933	$1.47M	6.5%	-93.3%	0.750%
2/14/2024	Verition Fund Management LLC	703,000	$15.66M	0.1%	-92.2%	7.996%
2/14/2024	Wildcat Capital Management LLC	16,756	$0.37M	0.1%	N/A	0.191%
2/13/2024	CIBC Asset Management Inc	173,868	$3.87M	0.0%	-90.5%	1.978%
2/12/2024	DLD Asset Management LP	10,000	$0.22M	0.0%	N/A	0.114%
2/5/2024	Victory Capital Management Inc.	15,705	$0.35M	0.0%	+25.0%	0.179%
2/2/2024	Simplex Trading LLC	1,392	$31K	0.0%	N/A	0.016%
12/6/2023	Citigroup Inc.	83,115	$0.14M	0.0%	+44,585.5%	0.969%
11/15/2023	Acuta Capital Partners LLC	4,485,000	$7.67M	5.1%	+5.5%	3.489%
11/15/2023	Adage Capital Partners GP L.L.C.	8,780,000	$15.01M	0.0%	+10.7%	6.830%
11/14/2023	Schonfeld Strategic Advisors LLC	632,543	$1.08M	0.0%	-12.1%	0.492%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	56,130	$96K	0.0%	+45.0%	0.044%
11/13/2023	Acadian Asset Management LLC	1,434,474	$2.45M	0.0%	-7.0%	1.116%
11/13/2023	Silverarc Capital Management LLC	4,117,920	$7.04M	2.1%	+18.5%	3.203%
11/7/2023	Jump Financial LLC	32,659	$56K	0.0%	N/A	0.025%
10/30/2023	CIBC Asset Management Inc	1,825,910	$3.12M	0.0%	+19.3%	1.420%
10/24/2023	Bank of New York Mellon Corp	75,077	$0.13M	0.0%	+409.5%	0.058%
8/15/2023	Silverarc Capital Management LLC	3,476,162	$4M	1.2%	N/A	5.424%
8/15/2023	Sphera Funds Management LTD.	8,764,334	$10.08M	1.6%	N/A	13.675%
8/14/2023	Cormorant Asset Management LP	9,500,000	$10.93M	0.6%	N/A	14.823%
8/11/2023	VR Adviser LLC	5,304,410	$6.10M	1.0%	N/A	8.277%
8/11/2023	Harvard Management Co. Inc.	692,617	$0.80M	0.1%	-11.0%	1.081%
8/7/2023	Principal Financial Group Inc.	31,771	$37K	0.0%	+66.6%	0.050%
8/7/2023	Acadian Asset Management LLC	1,543,217	$1.77M	0.0%	+10.5%	2.408%
8/4/2023	Maven Securities LTD	1,351,442	$1.55M	0.0%	N/A	2.109%
5/16/2023	Great Point Partners LLC	2,032,550	$1.64M	0.3%	N/A	3.507%
5/16/2023	Baker BROS. Advisors LP	1,879,915	$1.52M	0.0%	+2.7%	3.243%
5/15/2023	Kingdon Capital Management L.L.C.	4,700,000	$3.80M	0.7%	+64.6%	8.109%

Data available starting January 2016

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase III clinical trial for the treatment of essential tremor; PRAX-562 for the treatment of pediatric patients with developmental and epileptic encephalopathies (DEE); and PRAX-628 to treat focal epilepsy. The company also develops PRAX-222 for the treatment of pediatric patients with early-onset SCN2A-DEE; PRAX-020 to treat KCNT1 related epilepsies; PRAX-080 for the treatment of PCDH19; and PRAX-090 and PRAX-100 for SYNGAP1 and SCN2A-LoF. It has a license agreement with RogCon Inc.; a research collaboration and license agreement with Ionis Pharmaceuticals, Inc.; a strategic collaboration and license agreement with UCB Biopharma SRL; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Boston, Massachusetts.

Today's Range

Now: $71.76

$69.54

$77.00

50 Day Range

MA: $67.00

$56.55

$84.83

52 Week Range

Now: $71.76

$13.98

$86.93

Volume

551,065 shs

Average Volume

282,749 shs

Market Capitalization

$1.34 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.67

Who are the company insiders with the largest holdings of Praxis Precision Medicines?: Praxis Precision Medicines' top insider investors include:
Marcio Souza (CEO)
Alex Nemiroff (General Counsel)
Lauren Mastrocola (Insider)
Dean J Mitchell (Director)
Jill Desimone (Director)
Learn More about top insider investors at Praxis Precision Medicines.
Who are the major institutional investors of Praxis Precision Medicines?: Praxis Precision Medicines' top institutional investors include:
State Street Corp — 4.24%
RA Capital Management L.P. — 4.09%
Verition Fund Management LLC — 3.00%
Janus Henderson Group PLC — 2.81%
Baker BROS. Advisors LP — 1.73%
FMR LLC — 1.47%
Learn More about top institutional investors of Praxis Precision Medicines stock.
Which major investors are selling Praxis Precision Medicines stock?: In the last quarter, PRAX stock was sold by these institutional investors:
RA Capital Management L.P.
PFM Health Sciences LP
Verition Fund Management LLC
Acuta Capital Partners LLC
Ally Bridge Group NY LLC
State Street Corp
Jacobs Levy Equity Management Inc.
FMR LLC
During the previous year, company insiders that have sold Praxis Precision Medicines company stock include:
Marcio Souza (CEO)
Alex Nemiroff (General Counsel)
Learn More investors selling Praxis Precision Medicines stock.
Which major investors are buying Praxis Precision Medicines stock?: During the previous quarter, PRAX stock was bought by institutional investors including:
Baker BROS. Advisors LP
Wellington Management Group LLP
Janus Henderson Group PLC
Charles Schwab Investment Management Inc.
CIBC Asset Management Inc
Walleye Capital LLC
Sphera Funds Management LTD.
Barclays PLC
In the last year, these company insiders have bought Praxis Precision Medicines stock:
Marcio Souza (CEO)
Alex Nemiroff (General Counsel)
Lauren Mastrocola (Insider)
Learn More investors buying Praxis Precision Medicines stock.